SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551152-21-000003
Filing Date
2021-02-03
Accepted
2021-02-03 07:41:10
Documents
16
Period of Report
2021-02-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abbv-20210203.htm   iXBRL 8-K 64753
2 EX-99.1 abbv-20201231xexhibit991.htm EX-99.1 589637
8 logoabbviea061a.gif GRAPHIC 2573
  Complete submission text file 0001551152-21-000003.txt   962808

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20210203.xsd EX-101.SCH 4989
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abbv-20210203_cal.xml EX-101.CAL 799
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20210203_def.xml EX-101.DEF 21866
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20210203_lab.xml EX-101.LAB 45361
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20210203_pre.xml EX-101.PRE 22687
9 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20210203_htm.xml XML 32108
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 21584212
SIC: 2834 Pharmaceutical Preparations